RD
Rapid Dose Therapeutics Corp.
RDTCF · OTC
$0.09 +0.00% (+$0.00)
1M +0.00%
Market Cap $16.0M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.13
52.9% upside
Current Price
$0.085
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RDTCF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
23 /100
Expensive P/S 6.21x
PEG N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 56.88%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 123.07%
Op. margin 68.99%
FCF margin 90.72%
Quality
72 /100
Excellent ROA 101.41%
Asset turnover 0.82x
ROIC 102.39%
Debt
0 /100
High Int. coverage -1.49x
Current ratio 0.04x
Net debt/EBITDA N/A
Stability
38 /100
Moderate Rev. volatility 38.90%
EPS volatility 24.52%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RDTCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark Andrew Upsdell
Employees
12
Headquarters
Burlington